CRIS Current Research Information System

LOGGI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.908
EU - Europa 1.782
AS - Asia 943
AF - Africa 119
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.898
GB - Regno Unito 512
CN - Cina 358
SE - Svezia 348
SG - Singapore 239
DE - Germania 224
IT - Italia 185
VN - Vietnam 173
IN - India 100
UA - Ucraina 100
IE - Irlanda 86
RU - Federazione Russa 85
FR - Francia 66
TG - Togo 51
BE - Belgio 40
ZA - Sudafrica 39
EE - Estonia 34
JO - Giordania 32
CH - Svizzera 21
FI - Finlandia 17
GR - Grecia 15
BG - Bulgaria 13
IR - Iran 12
NL - Olanda 11
SC - Seychelles 11
CA - Canada 10
CI - Costa d'Avorio 9
JP - Giappone 8
NG - Nigeria 6
ES - Italia 5
LB - Libano 5
PL - Polonia 5
BR - Brasile 4
HK - Hong Kong 4
RO - Romania 4
AT - Austria 3
CL - Cile 3
DK - Danimarca 3
TR - Turchia 3
BD - Bangladesh 2
KR - Corea 2
PK - Pakistan 2
PT - Portogallo 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
NO - Norvegia 1
RS - Serbia 1
TW - Taiwan 1
Totale 5.762
Salva come PNG Salva come JPEG
Città #
Southend 459
Fairfield 366
Chandler 341
Singapore 220
Ashburn 213
Woodbridge 180
Ann Arbor 175
Dong Ket 158
Houston 152
Seattle 149
Wilmington 148
Santa Clara 143
Cambridge 134
Princeton 111
Dublin 86
Boardman 72
Jacksonville 63
Lomé 51
Nanjing 49
Westminster 47
Padova 44
Brussels 39
Amman 32
Jinan 32
Bologna 29
Beijing 27
Berlin 26
San Diego 24
Changsha 22
Turin 22
Shenyang 21
Hebei 17
Nanchang 16
Bern 15
Bremen 15
Helsinki 15
Saint Petersburg 15
Mülheim 13
Sofia 12
Mahé 11
Zhengzhou 11
Florence 10
Milan 10
Tianjin 10
Abidjan 9
Des Moines 9
Guangzhou 9
Ningbo 9
Redmond 9
Dearborn 8
Kunming 8
Taizhou 8
Tokyo 8
Yubileyny 8
Dolo 7
Abeokuta 6
Haikou 6
Jiaxing 6
Lanzhou 6
Los Angeles 6
Medford 6
New York 6
Redwood City 6
San Francisco 6
Toronto 6
Zola Predosa 6
Amsterdam 5
Falls Church 5
Frankfurt Am Main 5
Frankfurt am Main 5
Norwalk 5
Paris 5
Phoenix 5
San Venanzo 5
Shanghai 5
Washington 5
Andover 4
Falkenstein 4
Foshan 4
Hangzhou 4
London 4
Monmouth Junction 4
Olalla 4
São Paulo 4
Taiyuan 4
Zanjan 4
Costa Mesa 3
Fuzhou 3
Hyderabad 3
Las Vegas 3
Leawood 3
Moscow 3
Mountain View 3
Quanzhou 3
Rome 3
Sacramento 3
Verona 3
Xi'an 3
Ardabil 2
Athens 2
Totale 4.093
Salva come PNG Salva come JPEG
Nome #
Adaptive response in Hepatitis B virus infection 202
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 166
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 148
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 145
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 143
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 140
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 139
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 138
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 138
Chronic hepatitis B: Are we close to a cure? 138
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B 137
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 136
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 135
Vitamins in the treatment of chronic viral hepatitis. 135
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 135
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 128
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 126
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 126
Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis 124
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. 122
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 122
Hepatitis B virus and immune response. 121
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. 121
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 120
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 119
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis 118
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" 117
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 114
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. 111
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 109
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. 107
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study. 107
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 105
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). 105
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 99
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C. 98
null 98
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 96
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 95
Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire 95
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 93
null 92
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 89
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection 81
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection. 79
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses 75
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 75
Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. 70
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 64
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 60
SPONTANEOUS MOBILIZATIONOF BONE MARROW-DERIVED HEMATOPOIETIC AND ENDOTHELAIL PROGENITOR CELLS AFTER ORTHOTOPIC LIVER TRANSPALNTATION (OLT). 59
Proteomics of immune cells from liver tumors reveals immunotherapy targets 17
METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY 13
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 5
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 4
Virological Treatment Monitoring for Chronic Hepatitis B 1
Totale 5.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020643 0 0 0 0 0 0 0 190 208 97 44 104
2020/2021693 137 71 12 29 9 27 17 51 55 32 41 212
2021/20221.108 76 32 93 118 83 58 18 61 46 107 229 187
2022/20231.165 140 204 65 164 62 99 28 47 192 32 84 48
2023/2024257 17 55 21 34 24 32 11 29 5 15 3 11
2024/2025693 32 182 63 104 198 47 55 12 0 0 0 0
Totale 5.855